Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 83%
In fiscal 2025, BIOLARGO, INC. reported revenue of $8M, down 56.3% year over year. Operating margin was -191.3% and net margin -195.6%, on a free-cash-flow margin of n/a with capital expenditure at n/a of revenue. Every figure is computed directly from BLGO's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $8M | -191.3% | -195.6% |
| FY2024 | $18M | -24.4% | -24.5% |
| FY2023 | $12M | -37.4% | -38.0% |
| FY2022 | $6M | -91.6% | -87.2% |
| FY2021 | $3M | -267.8% | -272.4% |
How does BLGO compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.